waterproof watches, and eyewear frames • Healthcare products – ISO and USP pre-tested solutions are sold as Mevopur™ Healthcare Functional Additives BENEFITS • Produces strong, durable, and consistent seams • Available for polyolefins, TPE, ABS, SAN, PA, PC, PMMA, and others on request • Delivered as concentrates or ready-to-use formulations • Can be combined with color into a single product • Specific regulatory compliance available on request, e.g., UL 94 recognition, EU and US food contact • Product guidance from our experts PRODUCT BULLETIN Copyright © 2023, Avient Corporation.

Polypropylene (PP) Polyethylene (PE) Polystyrene (PS) Thermoplastic Elastomer (TPE) Thermoplastic Polyurethane (TPU) Polyamide (PA) Copolyester (CoPET) Thermoplastic Vulcanizates (TPV) Polycarbonate (PC) Acrylonitrile Butadiene Styrene (ABS) Polycarbonate/ABS (PC/ABS) www.avient.com Copyright © 2020, Avient Corporation.

Always adhere to the principles of honesty, frankness and forthrightness in the sale of the Company’s products, including the advertising and promotion of those products. 17.

Reconciliation of Pro Forma Adjusted Earnings per Share: Year Ended December 31, 2020 Net income from continuing operations attributable to Avient shareholders $ 132.0 Special items, after tax 24.8 Adjusted net income from continuing operations excluding special items 156.8 Clariant Color pro forma adjustments to net income from continuing operations(2) 20.7 Pro forma adjusted net income from continuing operations attributable to Avient shareholders $ 177.5 Weighted average diluted shares 90.6 Pro forma impact to diluted shares from January 2020 equity offering(2) 1.5 Pro forma weighted average diluted shares 92.1 Adjusted EPS - excluding special items pro forma for Clariant Color acquisition $ 1.93 Year Ended December 31, 2020 Sales $ 3,242.1 Clariant Color pro forma adjustment to sales(2) 540.4 Pro forma sales $ 3,782.5 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 15 Reconciliation of Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) by Segment Three Months Ended December 31, Year Ended December 31, 2021 2020 2021 2020 Operating income: Color, Additives and Inks $ 61.2 $ 57.5 $ 303.1 $ 180.8 Specialty Engineered Materials 28.8 30.4 132.0 94.4 Distribution 21.7 18.0 93.2 69.5 Corporate and eliminations (37.7) (40.9) (147.1) (155.4) Operating income $ 74.0 $ 65.0 $ 381.2 $ 189.3 Items below OI in Corporate: Other income, net $ (5.4) $ 11.7 $ (1.3) $ 24.3 Depreciation & amortization: Color, Additives and Inks $ 26.4 $ 27.3 $ 105.7 $ 75.1 Specialty Engineered Materials 8.0 7.4 31.7 30.0 Distribution 0.2 0.3 0.8 0.7 Corporate and eliminations 3.6 2.8 7.7 9.3 Depreciation & Amortization $ 38.2 $ 37.8 $ 145.9 $ 115.1 EBITDA: Color, Additives and Inks $ 87.6 $ 84.8 $ 408.8 $ 255.9 Specialty Engineered Materials 36.8 37.8 163.7 124.4 Distribution 21.9 18.3 94.0 70.2 Corporate and eliminations (39.5) (26.4) (140.7) (121.8) EBITDA $ 106.8 $ 114.5 $ 525.8 $ 328.7 16 Reconciliation of Pro Forma Sales, Operating Income and EBITDA - Color, Additives and Inks Year Ended December 31, 2020 Sales: Color, Additives and Inks $ 1,502.9 Clariant Color pro forma adjustments(2) 540.4 Pro forma sales $ 2,043.3 Operating income: Color, Additives and Inks $ 180.8 Clariant Color pro forma adjustments(2) 45.0 Pro forma operating income $ 225.8 Depreciation & amortization: Color, Additives and Inks $ 75.1 Clariant Color pro forma adjustments(2) 30.1 Pro forma depreciation & amortization $ 105.2 EBITDA: Color, Additives and Inks $ 255.9 Clariant Color pro forma adjustments(2) 75.1 Pro forma EBITDA $ 331.0 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition Three Months Ended December 31, Year Ended December 31, Reconciliation to EBITDA and Pro Forma Adjusted EBITDA: 2021 2020 2021 2020 Net income from continuing operations – GAAP $ 28.9 $ 74.7 $ 230.6 $ 133.8 Income tax expense (benefit) 22.2 (17.3) 74.0 5.2 Interest expense 17.5 19.3 75.3 74.6 Depreciation and amortization from continuing operations 38.2 37.8 145.9 115.1 EBITDA $ 106.8 $ 114.5 $ 525.8 $ 328.7 Special items, before tax 20.6 4.2 57.1 66.2 Interest expense included in special items — — (10.1) Depreciation and amortization included in special items (1.6) (0.7) (1.7) (3.2) Adjusted EBITDA $ 125.8 $ 118.0 $ 581.2 $ 381.6 Clariant Color pro forma adjustments(2) — — — 75.1 Pro forma adjusted EBITDA $ 125.8 $ 118.0 $ 581.2 $ 456.7 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 17 Net Debt Calculation December 31, 2021 Total long-term debt, net $ 1,850.3 Unamortized discount and debt issuance cost 14.4 Short-term and current portion of long term debt 8.6 Total debt $ 1,873.3 Cash (601.2) Net debt $ 1,272.1 NEWS RELEASE Attachment 1

Reconciliation of Pro Forma Adjusted Earnings per Share: Nine Months Ended September 30, 2020 Year Ended December 31, 2020 Net income from continuing operations attributable to Avient shareholders $ 57.8 $ 132.0 Special items, after tax 42.0 24.8 Adjusted net income from continuing operations excluding special items 99.8 156.8 Clariant MB pro forma adjustments to net income from continuing operations(2) 20.7 20.7 Pro forma adjusted net income from continuing operations attributable to Avient shareholders $ 120.5 $ 177.5 Weighted average diluted shares 90.7 90.6 Pro forma impact to diluted shares from January 2020 equity offering(2) 2.9 1.5 Pro forma weighted average diluted shares 93.6 92.1 Adjusted EPS - excluding special items pro forma for Clariant MB acquisition $ 1.29 $ 1.93 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 15 Nine Months Ended September 30, 2020 Reconciliation of Pro Forma Adjusted Earnings per Share: Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(2) Pro Forma Adjusted Avient Sales $ 2,245.1 $ — $ 2,245.1 $ 540.5 $ 2,785.6 Operating income $ 124.3 $ 59.1 $ 183.4 $ 45.0 $ 228.4 Interest expense, net (55.3) — (55.3) (18.1) (73.4) Pension settlement gain and mark-to-market adjustment — (6.9) (6.9) — (6.9) Other income, net 12.6 0.3 12.9 — 12.9 Income taxes (22.5) (10.5) (33.0) (6.2) (39.2) Net income attributable to noncontrolling interests (1.3) — (1.3) — (1.3) Net income from continuing operations attributable to Avient shareholders $ 57.8 $ 42.0 $ 99.8 $ 20.7 $ 120.5 Weighted average diluted shares 90.7 Impact to diluted shares from January 2020 equity offering 2.9 Pro forma weighted average diluted shares 93.6 Pro forma adjusted EPS $ 1.29 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition 16 Reconciliation of EBITDA by Segment Three Months Ended September 30, Nine Months Ended September 30, 2021 2020 2021 2020 Operating income: Color, Additives and Inks $ 66.8 $ 50.5 $ 241.9 $ 123.3 Specialty Engineered Materials 31.7 24.7 103.2 64.0 Distribution 23.8 17.5 71.5 51.5 Corporate and eliminations (43.6) (59.2) (109.4) (114.5) Operating income $ 78.7 $ 33.5 $ 307.2 $ 124.3 Items below OI in Corporate: Other income, net $ 1.4 $ 1.5 $ 4.1 $ 12.6 Depreciation & amortization: Color, Additives and Inks $ 26.6 $ 26.3 $ 79.2 $ 48.0 Specialty Engineered Materials 7.9 7.5 23.8 22.7 Distribution 0.2 0.2 0.6 0.4 Corporate and eliminations 2.1 2.5 4.1 6.2 Depreciation & Amortization $ 36.8 $ 36.5 $ 107.7 $ 77.3 EBITDA: Color, Additives and Inks $ 93.4 $ 76.8 $ 321.1 $ 171.3 Specialty Engineered Materials 39.6 32.2 127.0 86.7 Distribution 24.0 17.7 72.1 51.9 Corporate and eliminations (41.5) (56.7) (105.3) (108.3) EBITDA $ 116.9 $ 71.5 $ 419.0 $ 214.2 EBITDA as a % of Sales: Color, Additives and Inks 15.9 % 15.6 % 17.6 % 17.5 % Specialty Engineered Materials 17.0 % 18.5 % 18.4 % 16.7 % Distribution 5.5 % 6.4 % 6.0 % 6.4 % 17 Reconciliation of Pro Forma EBITDA - Color, Additives and Inks Nine Months Ended September 30, 2020 Sales: Color, Additives and Inks $ 977.1 Clariant MB pro forma adjustments(2) 540.5 Pro forma sales $ 1,517.6 Operating income: Color, Additives and Inks $ 123.3 Clariant MB pro forma adjustments(2) 45.0 Pro forma operating income $ 168.3 Depreciation & amortization: Color, Additives and Inks $ 48.0 Clariant MB pro forma adjustments(2) 30.1 Pro forma depreciation & amortization $ 78.1 Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA): Color, Additives and Inks $ 171.3 Clariant MB pro forma adjustments(2) 75.1 Pro forma EBITDA $ 246.4 Pro forma EBITDA as a % of Sales 16.2 % (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition Three Months Ended September 30, Nine Months Ended September 30, Reconciliation to EBITDA and Pro Forma Adjusted EBITDA: 2021 2020 2021 2020 Net income from continuing operations – GAAP $ 52.6 $ 2.6 $ 201.7 $ 59.1 Income tax expense 8.5 2.7 51.8 22.5 Interest expense 19.0 29.7 57.8 55.3 Depreciation and amortization from continuing operations 36.8 36.5 107.7 77.3 EBITDA $ 116.9 $ 71.5 $ 419.0 $ 214.2 Special items, before tax 19.9 50.0 36.5 62.0 Interest expense included in special items — (9.6) — (10.1) Depreciation and amortization included in special items (0.9) (1.3) (0.1) (2.5) Adjusted EBITDA $ 135.9 $ 110.6 $ 455.4 $ 263.6 Clariant MB pro forma adjustments(2) — — — 75.1 Pro forma adjusted EBITDA $ 135.9 $ 110.6 $ 455.4 $ 338.7 (2) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition NEWS RELEASE Attachment 1

Ostaja nimenomaisesti takaa, että Ostajan työntekijät, edustajat ja alihankkijat eivät suoraan tai välillisesti (i) hyväksy, lupaa, tarjoa tai anna mitään sopimatonta etua tai (ii) tee sopimusta (a) minkään yhteisön tai henkilön kanssa, mukaan lukien hallituksen tai valtion määräysvallassa olevan yksikön virkamiesten kanssa, tai (b) tuotteeseen liittyen, mikä merkitsisi sovellettavien Lakien ja standardien rikkomista. 17.

A Vevő kifejezetten garantálja, hogy a Vevő alkalmazottai, ügynökei és alvállalkozói sem közvetlenül sem közvetve nem (i) fogadnak el, ígérnek meg, ajánlanak fel vagy nyújtanak bármilyen jogosulatlan előnyt, vagy (ii) lépnek szerződésbe (a) bármely entitással vagy személlyel, beleértve a kormány vagy kormány által irányított entitás hivatalnokait, vagy (b) egy termékkel kapcsolatban, amely bűncselekményt vagy jogsértést jelentene az alkalmazandó Törvények és Szabályok szerint. 17.

Seller has based any recommendations to Buyer upon information that Seller considers reliable, but Seller makes no warranty as to any results Buyer might obtain in Buyer’s use(s) for the Product. 8 agents and subcontractors of Buyer shall not directly or indirectly (i) accept, promise, offer or provide any improper advantage to, or (ii) enter into an agreement (a) with any entity or person, including officials of a government or a government-controlled entity, or (b) relating to a product, which would constitute an offense or infringement of applicable Laws and Standards. 17. No modification or addition to the contract shall occur by the acknowledgment or acceptance by Seller of a purchase order, acknowledgment, release or other form submitted by Buyer containing additional or different terms or conditions. 17.

For more information on product specific test results, please click here to view to the 2014 PolyOne Wilflex General EH&S Conformity Statement Wilflex Compliance or visit www.wilflex.com/compliance.

The Circular Solution for Dyneema® is a testament to Dyneema®’s legacy of innovation, further exemplified by the recent introduction of their third-generation fiber and corresponding ballistic material technology.